Buscar resultados de ensayos clínicos
Fibrosarcoma - 88 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Condición:
|
Completed |
Nombre del estudio: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Condición:
|
Completed |
Nombre del estudio: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Condición:
|
Completed |
Nombre del estudio: Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate Condición: Cancer Fecha: 2010-01-11 Intervenciones:
|
Terminated |
Nombre del estudio: Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Condición: Sarcoma Fecha: 2008-08-22 Intervenciones:
|
Completed |
Nombre del estudio: Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Condición:
Intervenciones: Drug: sunitinib malate |
Withdrawn |
Nombre del estudio: Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma Condición:
Fecha: 2006-06-07 Intervenciones:
|
Withdrawn |
Nombre del estudio: Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Condición:
Fecha: 2006-06-07 Intervenciones:
|
Completed |
Nombre del estudio: Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Condición: Life Threatening Diseases Fecha: 2005-09-09 Intervenciones: Drug: Imatinib mesylate |
Completed |
Nombre del estudio: Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans Condición: Dermatofibrosarcoma Protuberans Fecha: 2005-10-20 Intervenciones: Drug: imatinib mesylate 400 mg orally twice a day for 10 - 14 days |